49.56
Livanova Plc 주식(LIVN)의 최신 뉴스
LivaNova (LIVN) Is Up 18.7% After Strong Q2 Results and Raised 2025 Guidance – What's Changed - simplywall.st
Jefferies Reaffirms ‘Buy’ Rating on LivaNova PLC (LIVN) with $79 PT - MSN
How hedge fund analytics apply to LivaNova PLC stockAI Intraday Market Movement Prediction Tool - Newser
LivaNova PLC (NASDAQ:LIVN) Receives Average Recommendation of “Buy” from Analysts - Defense World
LivaNova PLC stock trend forecastFree High Accuracy Alerts for ROI Traders - Newser
Can machine learning forecast LivaNova PLC recoveryFree Trade Ready Stock Watch for Short Term - Newser
Chart based exit strategy for LivaNova PLCConsistent Return Setup with Exit Strategy - Newser
LivaNova (NASDAQ:LIVN) Upgraded by Wall Street Zen to “Strong-Buy” Rating - Defense World
LivaNova PLC Company Revenue and Profit Trends: A Deep DiveSmart Risk Strategy with Entry Optimization - Newser
Real time scanner hits for LivaNova PLC explainedInvestment Position Summary with Timeframe Forecast - Newser
LivaNova PLC Reports Strong Q2 Earnings and Raised Guidance - The Globe and Mail
LivaNova (LIVN) Is Up 18.0% After Raising 2025 Outlook and Advancing Core Technology Platforms - simplywall.st
LivaNova PLC (NASDAQ:LIVN) Q2 2025 Earnings Call Transcript - Insider Monkey
Goldman Sachs raises Livanova stock price target to $168 on strong 2Q25 - Investing.com UK
LivaNova raises 2025 organic growth outlook to 9%-10% with upgraded guidance for cardiopulmonary and epilepsy - MSN
Livanova stock price target raised to $65 from $55 at Mizuho - Investing.com Canada
LIVN Stock Price and Chart — NASDAQ:LIVN - TradingView
LivaNova Q2 2025 revenue increased 10.7% to USD 352.5M - Medical Buyer
Decoding LivaNova PLC (LIVN): A Strategic SWOT Insight - GuruFocus
LivaNova PLC Reports Strong Q2 2025 Results - TipRanks
LivaNova PLC (LIVN): Accelerating Growth in Neuromodulation and Cardiopulmonary Markets - AInvest
LivaNova Has Found New Opportunities for Innovation in Its Strongholds - Morningstar
LivaNova Q2 2025 Earnings Call Transcript - MarketBeat
Transcript : LivaNova PLC, Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
LivaNova stock rises before hours on Q2 beats, raised guidance - MassDevice
LivaNova: Q2 Earnings Snapshot - The Washington Post
LivaNova PLC reports results for the quarter ended June 30Earnings Summary - TradingView
LivaNova Exceeds Q2 Earnings Expectations with Robust GrowthNews and Statistics - IndexBox
LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
LivaNova's Outperformance and Strategic Momentum in 2025: Why Revenue, Margin Expansion, and Clinical Innovation Justify a Buy Now Position in Medical Tech - AInvest
LIVN Forecasts Higher Revenue Growth for 2025 - GuruFocus
LivaNova Q2 Adjusted Earnings, Revenue Rise; Raises 2025 Adjusted Earnings Guidance - MarketScreener
LivaNova PLC Q2 2025 Earnings: EPS of $1.05 Beats Estimate, Reve - GuruFocus
LivaNova PLC earnings beat by $0.18, revenue topped estimates - Investing.com
LivaNova results exceed second-quarter expectations - Investing.com India
LivaNova's Strategic Momentum and Clinical Innovation: A Catalyst for Sustained Growth in 2025 - AInvest
LivaNova results exceed second-quarter expectations By Investing.com - Investing.com Canada
LivaNova Reports Second-Quarter 2025 Results; Raises 2025 Guidan - GuruFocus
LivaNova beats estimates for Q2 revenue, raises FY guidance - MarketScreener
(LIVN) LivaNova PLC Expects FY Adjusted EPS Range $3.70$3.80 - MarketScreener
Earnings Flash (LIVN) LivaNova PLC Reports Q2 Revenue $352.5M, vs. FactSet Est of $332.2M - MarketScreener
Earnings Flash (LIVN) LivaNova PLC Posts Q2 Adjusted EPS $1.05 per Share, vs. FactSet Est of $0.87 - MarketScreener
LivaNova Reports Second-Quarter 2025 Results; Raises 2025 Guidance - TradingView
LivaNova plc (LIVN) Tops Q2 EPS by 18c ; Offers Guidance - StreetInsider
LivaNova Crushes Q2 Expectations: Revenue Jumps 11%, VNS Therapy Shows Breakthrough Results - Stock Titan
Jefferies Maintained a Buy Rating on LivaNova PLC (LIVN) - MSN
LivaNova PLC (NASDAQ:LIVN) Shares Bought by Cwm LLC - Defense World
Vicarious Surgical (NYSE:RBOT) vs. LivaNova (NASDAQ:LIVN) Head to Head Contrast - Defense World
Machine Learning Models Forecast LivaNova PLC UptickChart Driven High Reward Trading Setup Presented - metal.it
LivaNova PLC Receives Positive Rating from Jefferies - AInvest
Quantitative breakdown of LivaNova PLC recent moveFree Smart Allocation Stock Pick Insights - Newser
When is LivaNova PLC stock expected to show significant growthUnlock the power of real-time market data - Jammu Links News
What analysts say about LivaNova PLC stockAchieve breakthrough results with expert guidance - Jammu Links News
What markets is LivaNova PLC expanding into Is EDBL stock a good long term investment optionGet insider insights into market trends - Jammu Links News
12 Best Undervalued UK Stocks to Buy According to Analysts - Insider Monkey
How does LivaNova PLC generate profit in a changing economyPhenomenal capital appreciation - Jammu Links News
What institutional investors are buying LivaNova PLC stockCapitalize on high-yield stocks early - Jammu Links News
자본화:
|
볼륨(24시간):